Literature DB >> 23473757

BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer.

X D Ma1, G Q Cai, W Zou, Y H Huang, J R Zhang, D T Wang, B L Chen.   

Abstract

To evaluate the association between gene variations in BRIP1 (BRCA1-interacting protein 1) and the risk of cervical cancer, we examined eight single nucleotide polymorphisms (SNPs: rs2048718, rs12937080, rs4988344, rs6504074, rs4988345, rs4986764, rs4986763, and rs11079454) in the BRIP1 gene in cervical tissue from a Chinese population using the MassARRAY system. The participants enrolled included 454 cervical cancer patients and 562 healthy controls. Quantitative real-time reverse transcription PCR (qRT-PCR) was performed to examine the potential correlation between functional BRIP1 SNP genotypes and mRNA levels in cervical cancer tissues. Our results first showed that rs4986764, located in exon 18 in the BRIP1 gene, was significantly associated with cervical cancer (χ(2)=11.191, P=0.001, odds ratio (OR)=1.384, 95% confidence interval (CI)=1.144-1.675). Another significant association was observed for rs4986763 located in exon 20 in BRIP1 (χ(2)=4.988, P=0.026, OR=1.241, 95% CI=1.027-1.500). Strong linkage disequilibrium was observed in the rs11079454-rs4986763-rs4986764 SNP block (D'>0.9). The frequencies of haplotype T-T-T are higher in controls than in these patients (P=2.01E-5). Moreover, cervical cancer tissues with a homozygous C/C genotype for rs4986764 had the lowest level of BRIP1, which was 2.8 and 2.9-fold lower than the C/T heterozygote and the T/T homozygote, respectively. These findings indicate a role for BRIP1 gene variations in cervical cancer and may be informative for future genetic or biological studies on cervical cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23473757     DOI: 10.1016/j.bbrc.2013.02.089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Genetic evaluation of the variants using MassARRAY in non-small cell lung cancer among North Indians.

Authors:  Gh Rasool Bhat; Itty Sethi; Amrita Bhat; Sonali Verma; Divya Bakshi; Bhanu Sharma; Muddasser Nazir; Khursheed A Dar; Deepak Abrol; Ruchi Shah; Rakesh Kumar
Journal:  Sci Rep       Date:  2021-05-28       Impact factor: 4.379

2.  BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity.

Authors:  Wei Zou; Xiangdong Ma; Wei Hua; Biliang Chen; Yanhong Huang; Detang Wang; Guoqing Cai
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

Review 3.  Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence.

Authors:  Gabriela A Martínez-Nava; Julián A Fernández-Niño; Vicente Madrid-Marina; Kirvis Torres-Poveda
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

4.  Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype.

Authors:  Patricia Carrera-Lasfuentes; Angel Lanas; Luis Bujanda; Mark Strunk; Enrique Quintero; Santos Santolaria; Rafael Benito; Federico Sopeña; Elena Piazuelo; Concha Thomson; Angeles Pérez-Aisa; David Nicolás-Pérez; Elizabeth Hijona; Jesús Espinel; Rafael Campo; Marisa Manzano; Fernando Geijo; María Pellise; Manuel Zaballa; Ferrán González-Huix; Jorge Espinós; Llúcia Titó; Luis Barranco; Mauro D'Amato; María Asunción García-González
Journal:  Oncotarget       Date:  2017-05-30

5.  Four common polymorphisms of BRIP1 (rs2048718, rs4988344, rs4986764, and rs6504074) and cancer risk: evidence from 13,716 cancer patients and 15,590 cancer-free controls.

Authors:  Di Liu; Yi Zheng; Meng Wang; Yujiao Deng; Shuai Lin; Linghui Zhou; Pengtao Yang; Cong Dai; Peng Xu; Qian Hao; Dingli Song; Huafeng Kang; Zhijun Dai
Journal:  Aging (Albany NY)       Date:  2018-02-16       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.